NeoManna - Next Generation Insect-derived Antimicrobials

๐Ÿ“ Gilboa Municipal Council, Israel๐Ÿ—“ Founded 2021๐Ÿ‘ฅ 12 employees๐Ÿ’ฐ Last funded Oct 2023
NeoManna develops products derived from the black soldier fly (BSF) for livestock, aquaculture, and future human applications. The company uses novel BSF strains with properties tailored to specific high-value products and applications. NeoManna integrates an array of biotech, AI, entomological, and agricultural proficiencies to create premium solutions for feed additives, BSF colony management, BSF genetics, and modular SME solutions designed to change the global livestock and aquaculture value chains. The BSF consortium, recently formed by the Israeli Government, aims to grow and connect the different BSF industry players in Israel and deliver a full value chain concept and know-how. NeoManna is taking its place as a member of this BSF consortium. NeoManna is an AgChimedes Group company.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in NeoManna - Next Generation Insect-derived Antimicrobials?
NeoManna - Next Generation Insect-derived Antimicrobials has 1 investors on record on gritt.io, including 1 early-stage backers.
When did NeoManna - Next Generation Insect-derived Antimicrobials last raise funding?
The most recent investment in NeoManna - Next Generation Insect-derived Antimicrobials recorded on gritt.io was in October 2023.
When was NeoManna - Next Generation Insect-derived Antimicrobials founded?
NeoManna - Next Generation Insect-derived Antimicrobials was founded in 2021.
What industry is NeoManna - Next Generation Insect-derived Antimicrobials in?
NeoManna - Next Generation Insect-derived Antimicrobials operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is NeoManna - Next Generation Insect-derived Antimicrobials based?
NeoManna - Next Generation Insect-derived Antimicrobials is headquartered in Gilboa Municipal Council, Israel.